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INTRODUCTION
Studies of diverse kinds of mesenchymal stem cells (MSCs) 
have recently been extended to include MSCs from many dif-
ferent types of tissues. Although teeth are hard tissues, they 
contain stem cells originating from dental pulp, periodontal 
ligaments, apical papilla, and exfoliated deciduous teeth.1-3
MSCs modulate inflammatory reactions and suppress T-
cell proliferation.4 One of the mechanisms of immune modu-
lation by MSCs is the induction of regulatory T-cells (Tregs).5-8 
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Purpose: Most studies on immune tolerance of mesenchymal stem cells (MSCs) have been performed using MSCs derived from 
bone marrow, cord blood, or adipose tissue. MSCs also exist in the craniofacial area, specifically in teeth. The purpose of this study 
was to evaluate the mechanisms of immune tolerance of dental pulp-derived MSC (DP-MSC) in vitro and in vivo.
Materials and Methods: We isolated DP-MSCs from human dental pulp and co-cultured them with CD4+ T-cells. To evaluate the 
role of cytokines, we blocked TGF-β and IL-10, separately and together, in co-cultured DP-MSCs and CD4+ T-cells. We analyzed 
CD25 and FoxP3 to identify regulatory T-cells (Tregs) by fluorescence-activated cell sorting (FACS) and real-time PCR. We per-
formed alloskin grafts with and without DP-MSC injection in mice. We performed mixed lymphocyte reactions (MLRs) to check 
immune tolerance.
Results: Co-culture of CD4+ T-cells with DP-MSCs increased the number of CD4+CD25+FoxP3+ Tregs (p<0.01). TGF-β or/and IL-
10 blocking suppressed Treg induction in co-cultured cells (p<0.05). TGF-β1 mRNA levels were higher in co-cultured DP-MSCs 
and in co-cultured CD4+ T-cells than in the respective monocultured cells. However, IL-10 mRNA levels were not different. There 
was no difference in alloskin graft survival rate and area between the DP-MSC injection group and the non-injection group. None-
theless, MLR was reduced in the DP-MSC injected group (p<0.05).
Conclusion: DP-MSCs can modulate immune tolerance by increasing CD4+CD25+FoxP3+ Tregs. TGF-β1 and IL-10 are factors in 
the immune-tolerance mechanism. Pure DP-MSC therapy may not be an effective treatment for rejection, although it may module 
immune tolerance in vivo.
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In addition, soluble factors secreted from MSCs increase Tregs.7 
Early studies of MSCs with diverse functions were performed 
mainly using MSCs derived from bone marrow (BM-MSCs).5-7 
Because many kinds of MSCs have been found in different 
sources, MSC studies have expanded to study MSC character-
istics depending on the specific source of the MSCs.9-11 
Tolerance studies have indicated increased importance not 
only for solid organ transplantation but also for vascularized 
composite allotransplantation (VCA). Based on the concept of 
“like with like,” the numbers of hand transplantations and fa-
cial transplantations have been increasing, and satisfactory re-
sults have been reported.12,13 Immunosuppressive agents should 
be used throughout a patient’s life after VCA; however, side ef-
fects can include infection, malignancy, and diabetes. There-
fore, studies of the immune tolerance of MSCs associated with 
VCA have been performed to reduce the requirement for im-
munosuppressants.14 
MSCs of dental origin are known to modulate immune resp-
onses,3,15-18 although it is not yet known whether stem cells of 
various dental origins have the same mechanisms of immune 
tolerance as other stem cells. We investigated the mechanism 
of immune tolerance by dental pulp-derived MSC (DP-MSC). 
We analyzed CD4+CD25+FoxP3+ Tregs to evaluate the effect of 
DP-MSCs on immune tolerance. We also investigated the ef-
fects of the soluble factors TGF-β and IL-10, and we examined 
the immune tolerance effects in vivo.
MATERIALS AND METHODS
DP-MSC isolation and culture
We obtained normal human premolars extracted for orthodon-
tic purposes and isolated DP-MSCs from the extracted teeth 
according to a previously published method.19-22 The process 
was performed with the approval of our Institutional Review 
Board (Yonsei University, Gangnam Severance Hospital, IRB# 
3-2012-0082). We obtained teeth from a total of 6 patients. We 
cleaned the surface of the teeth with sterile normal saline. We 
then made a crack on the teeth by dental fissure burr in the ver-
tical direction and cut the teeth using a pin cutter. After that, we 
extracted the dental pulp. We cut the pulp tissues to a size of 
2×2×1 mm and cultured the pulp cells to produce outgrowths 
from the fragments.19,21 
Mesenchymal stem cell markers
We analyzed the membrane-associated molecules of the hu-
man DP-MSCs by fluorescence activated cell sorting (FACS). 
We analyzed CD13 (anti-human PE, eBioscience, San Diego, 
CA, USA), CD44 (anti-human Alexa Fluor 488, Molecular 
Probes, Rockford, IL, USA), CD73 (anti-human Alexa Fluor 488, 
Molecular Probes), CD90 (anti-human APC, Molecular Probes), 
CD105 (anti-human Alexa Fluor 488, Molecular Probes), CD31 
(anti-human PE, BD Pharmingen, San Jose, CA, USA), CD34 
(anti-human APC, Molecular Probes), and CD45 (anti-human 
PreCP-Cy5-5-A, Molecular Probes). 
PBMC isolation & CD4+ T-cell preparation
We isolated human peripheral blood mononuclear cells (PB-
MCs) from a healthy individual by density gradient centrifuga-
tion using the Ficoll-Hypaque. We isolated CD4+ T-cells from 
the PBMCs using CD4+ T-cell isolation kit (Miltenyi Biotec, Ber-
gisch Gladbach, Germany).7 We first counted the PBMCs and 
resuspended 1.0× 107 cells in 80 μL of MACS buffer [0.5% bo-
vine serum albumin in phosphate-buffered saline (PBS)]. We 
then added 20 μL of CD4 microbeads (Miltenyi Biotec) to the 
aspirated cells. We incubated the cell suspension for 15 min at 
4°C and then applied the prepared cells to an MS column (Milt-
enyi Biotec) in the magnetic field of the MACS separator. We 
collected the labeled cells on the tube after removing the col-
umn from the separator.
 
Co-culture with and without TGF-β and IL-10 blocking
We seeded 1.0×105 DP-MSCs per well on a six-well culture 
plate. We then added 3.0×105 CD4+ T-cells per well and incu-
bated the cultures for 72 h at 37°C. To determine the effects of 
TGF-β and IL-10 on immune tolerance of the DP-MSCs, we add-
ed anti-TGF-β (10 μg/mL; R&D systems, Minneapolis, MN, 
USA) and/or anti-IL-10 (0.05 μg/mL; R&D systems) to the co-
cultured DP-MSCs and CD4+ T-cells. The co-culture groups 
with blocking were TGF-β single block, IL-10 single block, and 
TGF-β and IL-10 double block. All of the cultures were grown 
for 72 h for FACS and for 24 h for real-time PCR.
 
CD25 and FoxP3 analysis by FACS
To identify Tregs, we labeled the CD4+ T-cells cultured for 72 h 
for surface CD4 and CD25 and for intracellular FoxP3. We used 
CD4-FITC (anti-human CD4, Miltenyi Biotec), CD25-PE (anti-
human CD25, BD Pharmingen) antibodies, and FoxP3-APC 
Table 1. List of Primer Pairs
Gene Sequence
GAPDH
Forward 5'-GGA GCC AAA AGG GTC ATC AT-3' (20 mer)
Reverse 5'-GTG ATG GCA TGG ACT GTG GT-3' (20 mer)
CD25
Forward 5'-ATC TGG TGG AAG ATC TCC CC-3' (20 mer)
Reverse 5'-CTG CTG AAA ACT GCC GTG AT-3' (20 mer)
FoxP3
Forward 5'-GCC ATG GAA ACA GCA CAT TC-3' (20 mer)
Reverse 5'-CTC ATT GAG TGT CCG CTG CT-3' (20 mer)
TGF-β1
Forward 5'-GCG GCA GCT GTA CAT TGA CT-3' (20 mer)
Reverse 5'-CCA CGT AGT ACA CGA TGG GC-3' (20 mer)
TGF-β2
Forward 5'-GGG TAC CTT GAT GCC ATC CC-3' (20 mer)
Reverse 5'-GCA ATA GGC CGC ATC CAA AG-3' (20 mer)
TGF-β3
Forward 5'-TGA GCA CAT TGC CAA ACA GC-3' (20 mer)
Reverse 5'-GAG GCA GAT GCT TCA GGG TT-3' (20 mer)
IL-10
Forward 5'-TCA CCT TCC AGT GTC TCG GA-3' (20 mer)
Reverse 5'-TAG CTG GGA TTA CAG GTG CG-3' (20 mer)
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(anti-human Foxp3, eBioscience). The final cell concentration 
for FACS was 1.0×105 cells/mL. We performed FACS using a BD 
FACS Canto II Flow Cytometer and the FACSDiva software 
(BD Biosciences, Piscataway, NJ, USA).
CD25, FoxP3, TGF-β1, 2, 3, and IL-10 analysis by 
semi-quantitative PCR and real-time PCR
After culturing them for 24 h, we analyzed CD4+ T-cells for CD25 
and FoxP3. We performed semi-quantitative PCR to analyze 
levels of CD25, FoxP3, IL-10, and TGF-β1, 2, and 3. We investi-
gated the cytokine origin and variation according to the cells, 
CD4+ T-cells or DP-MSC. We performed different experiments: 
DP-MSC monoculture, DP-MSC co-culture with CD4+ T-cells, 
CD4+ T-cell monoculture, and CD4+ T-cell co-culture with DP-
MSCs. Because we did not observe any difference between mo-



































































Fig. 1. DP-MSC surface marker analysis using flow cytometry. (A) CD13 positive, (B) CD44 positive, (C) CD73 positive, (D) CD90 positive, and (E) CD105 
positive. (F) CD31 negative, (G) CD34 negative, and (H) CD45 negative. These signals are shown as blue lines, while isotype matched control antibod-
ies are shown as red lines. DP-MSC, dental pulp-derived mesenchymal stem cell.
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Fig. 2. Changes in CD4+CD25+FoxP3+ Tregs upon DP-MSC co-culture 
with and without cytokine blocking. Statistical differences were as-
sessed by paired t tests (n=9). CD4+CD25+FoxP3+ Tregs increased in the 
co-cultured group (p=0.003) and decreased in the double-block group 
(p<0.01). The single-block groups also showed statistical differences 
(p<0.05). *p<0.05, †p<0.01. DP-MSC, dental pulp-derived mesenchymal 



























Fig. 3. Semi-quantitative PCR of CD25 (A) and FoxP3 (B). DP-MSC, den-
tal pulp-derived mesenchymal stem cell.
al-time PCR in CD25, FoxP3, IL-10, and TGF-β1. 
We isolated total RNA from the co-cultured CD4+ T-cells us-
ing TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The primer 
sequences are summarized in Table 1. We analyzed the real-
time PCR using the Applied Biosystems 7300 Real-Time PCR 
System (Applied Biosystems, Foster City, CA, USA). We checked 
the target amplification using dissociation curves. We analyzed 
the data using the competitive method (2^-ΔΔCt). 
DP-MSC injection in mouse alloskin graft model
We performed full-thickness alloskin grafts (3×3 cm) from 
C57BL/6(H-2b) mice to Balb/c(H-2d) mice. The experimental 
group received intraperitoneal injection of 0.2 mL PBS with 
1.0×106 DP-MSCs along with the graft. The control group re-
ceived intraperitoneal injection of 0.2 mL PBS without DP-
MSCs. We checked the status of the mice and took pictures of 
the grafts daily for 2 weeks. We harvested the spleens of the mice 
after 14 days. We calculated the size change of the grafts using 
IMT iSolution Lite (ver. 21.1, serial No. 818967021, IMT i-Solu-
tion, Burlington, ON, Canada).
Mixed lymphocyte reaction
We performed mixed lymphocyte reactions (MLRs) using the 
harvested spleen tissues. We compared the DP-MSC injection 
group with the non-injection group on postoperative day 14. 
We isolated responder cells using a naive CD4+ isolation kit 
(Miltenyi Biotec) and labeled them with 5 μM CFSE (Molecu-
lar probe, CFDA SE, Eugene, OR, USA). We seeded 2.0×105 re-
sponder cells per well in a 96-well round form plate. We treated 
stimulator cells with 50 μg/mL of mitomycin C (Sigma, St. 
Louis, MO, USA) and incubated them for 20 min at 37°C in the 
dark. We then washed the cell suspension with complete me-
dia three times. We then seeded 2.0×105 treated stimulator cells 
per well in the 96-well round form plate and incubated the 
mixed lymphocyte culture for 4 days. 
 
Statistical analysis
We used paired t-tests to analyze CD25 and FoxP3 in the co-cul-
ture experiments. We used Mann-Whitney U tests to analyze 
the results of the real-time PCR and MLRs. We used two-sam-
ple t-tests to analyze the alloskin graft survival areas. We ana-
lyzed the survival rate by the Kaplan-Meier method. Statistical 
analyses were conducted using SPSS version 23 (IBM SPSS Sta-
tistics, Armonk, NY, USA). Statistical significance was set at 
p<0.05.
RESULTS
Mesenchymal stem cell marker and proliferation
After re-culturing the cells for three-five passages, we checked 
the positive and negative MSC markers. CD13, CD44, CD73, 
CD90, and CD105 were expressed as positive markers. CD31, 
CD34, and CD45 were not expressed (Fig. 1). 
Regulatory T-cell variation in co-culture with blocking 
of TGF-β and IL-10 
FACS showed that the number of CD4+CD25+FoxP3+ Tregs was 
higher in the co-cultures of CD4+ T-cells and DP-MSCs than in 
the monocultures of CD4+ T-cells (p=0.003, paired t-test). Rel-
ative to that in the co-cultures without cytokine blocking, the 
number of Tregs was decreased in the co-cultures with single 
blocking of TGF-β or IL-10 (p=0.039 and 0.005, respectively, 
paired t-test). The decrease in the number of CD4+CD25+FoxP3+ 
Tregs in the co-cultures with double blocking was greater than 
that in the co-cultures with single blocking (p=0.001, paired t-
test); however, the difference was not cumulative (Fig. 2).
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CD25, FoxP3, TGF-β, and IL-10 semi-quantitative and 
real-time PCR analyses
After semi-quantitative PCR, the CD25 and FoxP3 bands from 
the CD4+ T-cells co-cultured with DP-MSCs were more intense 
than those from the monocultured CD4+ T-cells (Fig. 3). Real-
time PCR showed that the CD25 and FoxP3 mRNA levels in the 
CD4+ T-cells co-cultured with DP-MSCs were higher than those 
in the monocultured CD4+ T-cells (CD25, p=0.001; FoxP3, 
p=0.001; Mann-Whitney U tests) (Fig. 4). Likewise, the TGF-β1 
mRNA levels in the CD4+ T-cells co-cultured with DP-MSCs 
and in the DP-MSC co-cultured with CD4+ T-cells were higher 
than those in the respective monocultured cells (p=0.002; p= 
0.007; Mann-Whitney U tests). Although the IL-10 mRNA lev-
els were higher in the co-cultured cells relative to those in the 
respective monocultured cells, the differences were not statis-
tically significant.
Alloskin graft survival area depending on DP-MSC 
injection
We analyzed the survival area and the survival rate of alloskin 
grafts. Although the DP-MSC injection group showed an in-






































CD25 gene expression in CD4+ T-cell

































TGF-β1 gene expression in DP-MSC
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FoxP3 gene expression in CD4+ T-cell

































IL-10 gene expression in DP-MSC






































IL-10 gene expression in CD4+ T-cell
CD4+ T-cell monoculture CD4+ T-cells co-culture w/DP-MSC
Fig. 4. Real-time PCR of monocultured CD4+ T-cells and CD4+ T-cells co-cultured with DP-MSCs. (A and B) CD25 and FoxP3 expression was higher in 
the co-cultured CD4+ T-cells (p=0.001, Mann-Whitney U test). (C and D) TGF-β1 expression was higher in DP-MSCs co-cultured with CD4+ T-cells than 
in monocultured DP-MSCs (p=0.002, Mann-Whitney U test). There was no statistical difference in IL-10 expression. (E and F) TGF-β1 expression was 
higher in CD4+ T-cells co-cultured with DP-MSCs than in monocultured CD4+ T-cells (p=0.007, Mann-Whitney U test). Although IL-10 expression was 

















1 day 7 day3 day 14 day
Fig. 5. Skin survival rate and area. Although the DP-MSC injection group 
showed elevated data, there were no statistical differences. DP-MSC, 
dental pulp-derived mesenchymal stem cell.
PBS
DP-MSC
cant (Fig. 5). There was no statistical difference in survival rate.
Mixed lymphocyte reaction
We performed MLR analysis of splenocytes from Balb/c mice 
that received alloskin grafts with or without DP-MSCs. The re-
sponder cells were the splenocytes of the mice that received 
the grafts. The stimulator cells were the splenocytes of C57BL/6 
mice. We analyzed CD4+ splenocytes using CD4-APC and CFSE 
staining. The mice that received DP-MSCs showed decreased 
lymphocyte reaction, compared with the mice that did not re-
ceive DP-MSCs (p=0.04, Mann- Whitney U test) (Fig. 6).
DISCUSSION
Early studies of MSCs mostly used BM-MSCs.4,6 As the sources 
of MSCs were extended, research on MSCs was extended to 
stem cells derived from cord blood and other sources.9 MSCs 
from teeth are one kind of MSC from the craniofacial area.1,23 
MSCs of dental origin show similar MSC characteristics in terms 
of differentiation, multipleutic potential, and CD markers.23,24 
Shortly after research on MSCs began, MSCs were found to 
reduce inflammation.4,9,25 Impacting immune tolerance, MSCs 
have been shown to affect T-cells, B-cells, and dendritic cells.26 
In addition, it has been reported that the mechanisms of MSC 
immune modulation involve cell-to-cell contact and soluble 
factors.7,17 Immunological tolerance has mainly been addressed 
in the fields of immunology and transplantation. There has 
been an increasing amount of research on immune tolerance 
in plastic surgery as the success of VCA has increased. In par-
ticular, the use of MSCs has been reported to increase immu-
notolerance in allotransplantation.14,27
Characteristics of dental-origin stem cells have also been 
reported in terms of regeneration and inhibition of inflamma-
tion.24,28 There have been several studies on the immune toler-
ance and reduction of inflammation by dental-origin stem 
cells.3,15-18 Although there are various types of dental stem cells 
and mechanisms of immune tolerance, all the processes and 
mechanisms have not yet been elucidated. Dental-origin stem 
cells differ in biological characteristics, such as colony growth 
rate, proliferation, and differentiation, depending on their origin.24 
Although DP-MSCs have been shown to increase Tregs in 
vivo in order to generate immune tolerance, few studies of cy-
tokines have been performed in vitro. We investigated the ef-
fects of DP-MSCs on Treg variation. We used a blocking meth-
od to determine which cytokines affect the Treg variation. We 
also investigated the effects of DP-MSCs on immune tolerance 
in an alloskin graft mouse model.
In our study, CD4+CD25+FoxP3+ Treg was increased when 
CD4+ T-cells were co-cultured with DP-MSC rather than 
monocultured. Semi-quantitative PCR and real-time PCR re-
sults confirmed a significant increase in CD25 and FoxP3 
mRNAs. To determine the interplay factors, we investigated 
mRNA of TGF-β1 and IL-10, and we added cytokine blocks ex-
periments in the co-cultures. 
We designed 3×3 cm alloskin grafts. Some previous studies 
designed 1×1 cm alloskin grafts. We decided that a small-sized 
wound could not reflect the pure alloskin graft effect. We also 
intended to expose the recipient mice to more antigen. We ana-
lyzed alloskin grafts using two methods: survival rate and sur-
vival area. The actual alloskin graft was not completely necrotic 
at a certain time point. Therefore, we measured the alloskin 
graft survival area.
Our results suggest that DP-MSCs increase the expression of 
CD4+CD25+FoxP3+ Tregs in vitro and that TGF-β1 and IL-10 
are involved in the mechanism. CD4+CD25+FoxP3+ Tregs were 
more suppressed in the double-block assays, although the num-
bers of CD4+CD25+FoxP3+ Tregs were still higher than those in 
the CD4+ T-cell monocultures. Those results suggest that other 
factors are also involved. The levels of TGF-β1 mRNA signifi-
cantly increased in CD4+ T-cells co-cultured with DP-MSCs and 
in DP-MSCs co-cultured with CD4+ T-cells. We thought that 
the DP-MSCs were also affected by the CD4+ T-cells, suggesting 
that there was an interaction effect between the two cell types. 
That is somewhat different from previous reports in which cy-
tokines secreted from MSCs affected target T-cells.8,29 
Wada, et al.16 reported that MSCs require stimulating factors 
from activated PBMCs to exert their effects. Recently, the sur-
vival of MSCs was shown to be affected by a soluble factor 
from activated lymphocytes.30 We did not confirm which kind 
of cell elicited an effect at first or whether paracrine or auto-
crine effects had a greater impact. Although the difference in 
IL-10 mRNA was not statistically significant, CD4+CD25+ FoxP3+ 
Tregs were suppressed to levels similar to those caused by the 
TGF-β block. That result might be due to the higher potency of 
IL-10, even in small amounts. 
We investigated the protein production of CD25, FoxP3, 
TGF-β1, and IL-10 by ELISA. We also performed immunohis-
tochemical staining to observe Treg migration, TGF-β1, and IL-
10 in the alloskin graft area. However, none of those factors 
showed any meaningful difference (results not shown).
Although the DP-MSCs had a meaningful effect on the MLR, 
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they did not increase the survival rate or the survival area. We 
carefully considered that DP-MSC injection alone might not 
be enough to induce immune tolerance to inhibit the rejection 
of the alloskin grafts (Fig. 5). Many papers have suggested that 
MSC had immune modulation effect, and it was proved to ex-
tended survival rate or decreased rejection.27,31-33 MSC treat-
ment designs on in vivo studies on transplantation or skin graft 
model were different according to the dose, timing, immuno-
suppression, or radiation before transplantation.32,33 Whole-
body irradiation or immunosuppressants could be together 
used with DP-MSC injection; however, we wanted to observe 
the pure effect of the DP-MSCs in the allografts. We selected in-
traperitoneal injection as the cell delivery method, expecting 
a paracrine effect. We used 3×3 cm alloskin grafts. The purpose 
of using the large skin grafts, compared to mouse surface areas, 
was to prevent bias of spontaneous wound healing in grafts of 
smaller size (1×1 cm) and potential exposure to antigens. Al-
though DP-MSC injection mice had a meaningful MLR, it 
Fig. 6. MLR analysis.  The PBS-injection group showed a greater increase than the DP-MSC-injection group. (A) Responder cell incubation in PBS in-
jection group. (B) MLR with stimulator cells in the PBS injection group. (C) Responder cell incubation in DP-MSC injection group. (D) MLR with stimu-
lator cells in DP-MSC group. (E) The CFSE-labeled cells were analyzed. The number of labeled cells of the DP-MSC-injection group was smaller than 
that of the PBS-injection group. There were statistical differences (p=0.04, Mann-Whitney U test). *p<0.05. DP-MSC, dental pulp-derived mesenchymal 
stem cell; MLR, mixed lymphocyte reaction.
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might not be enough to prevent against rejection, compared 
to control groups. Sbano, et al.34 suggested that MSC treatment 
combined with immunosuppression therapy would be more 
effective than single MSC treatment.
We found that DP-MSCs increased CD4+CD25+FoxP3+ Treg 
levels and were involved in immune tolerance through the re-
duction of the MLR. We also found that the DP-MSCs were af-
fected by the surrounding cells and increased TGF-β1. Howev-
er, the DP-MSCs did not cause a significant increase in survival 
rate related with immune tolerance in the actual alloskin graft. 
That does not mean, however, that DP-MSCs have lower po-
tency than other MSCs. We need further study to compare 
DP-MSCs with other kinds of MSCs in the same conditions. In 
the future, it will be important to learn how MSCs interact with 
target cells and to understand roles played by MSCs and tar-
get cells. In addition, MSC therapy alone may not be effective 
as a practical application to generate immune tolerance. Fur-
ther study of the cell injection amount, timing, injection meth-
od, and buster of MSCs will be needed in the future.
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